Success Metrics

Clinical Success Rate
100.0%

Based on 12 completed trials

Completion Rate
100%(12/12)
Active Trials
0(0%)
Results Posted
17%(2 trials)

Phase Distribution

Ph phase_3
2
13%
Ph early_phase_1
2
13%
Ph phase_4
3
19%
Ph phase_2
4
25%
Ph phase_1
1
6%
Ph not_applicable
4
25%

Phase Distribution

3

Early Stage

4

Mid Stage

5

Late Stage

Phase Distribution16 total trials
Early Phase 1First-in-human
2(12.5%)
Phase 1Safety & dosage
1(6.3%)
Phase 2Efficacy & side effects
4(25.0%)
Phase 3Large-scale testing
2(12.5%)
Phase 4Post-market surveillance
3(18.8%)
N/ANon-phased studies
4(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

12 of 14 finished

Non-Completion Rate

14.3%

2 ended early

Currently Active

0

trials recruiting

Total Trials

16

all time

Status Distribution
Active(1)
Completed(12)
Terminated(2)
Other(1)

Detailed Status

Completed12
Withdrawn2
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (12.5%)
Phase 11 (6.3%)
Phase 24 (25.0%)
Phase 32 (12.5%)
Phase 43 (18.8%)
N/A4 (25.0%)

Trials by Status

unknown16%
not_yet_recruiting16%
completed1275%
withdrawn213%

Recent Activity

Clinical Trials (16)

Showing 16 of 16 trials
NCT06750653Phase 4

Skin Barrier Function and Inflammation in Aging: The BIA Study

Completed
NCT07408960Not Applicable

CO2Lift and T-Junction Breakdown Rates Evaluation After Breast Reduction Surgery Pilot Trial

Not Yet Recruiting
NCT07169032Early Phase 1

The Effect of Er,Cr:YSGG Laser-assisted Topical Anesthetic on Oral Mucosal Anesthesia

Completed
NCT04329221Phase 2

Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients

Withdrawn
NCT04642287Phase 2

Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients

Withdrawn
NCT05449392Phase 1

Topical Antibacterial Agents for Prevention of COVID-19

Completed
NCT03447925Phase 2

Treatment of Plantar Keratosis With Medicinal Plant in Diabetic Patients

Completed
NCT03279328Phase 4

Evaluating Skin Appearance Following 5-Flourouracil Cream for Treatment of Actinic Keratosis and the Effects of Topical Agents

Completed
NCT03946826Not Applicable

A Clinical Observation on the Efficacy and Safety of Pulsed Dye Laser (PDL) in the Treatment of Nail Psoriasis

Completed
NCT03095872Phase 3

Comparison of the Effect of Vaseline and Bepanthen® "Wund- Und Heilsalbe" on the Wound Healing Following Laser Therapy

Completed
NCT02801305Phase 2

Diltiazem Gel Versus Nitroglycerin Ointment in Healing Process of Scleroderma Digital Ulcers

Completed
NCT02019355Early Phase 1

Actinic Keratosis Study

Completed
NCT00812604Not Applicable

Analgesic Ointment on Temporomandibular Joint and Masticatory Muscle Pain

Completed
NCT01078428Phase 4

Effect of Transparent, Self-drying Silicone Gel on the Treatment of Hypertrophic Abdominal Scars

Completed
NCT01756664Not Applicable

The Use of Sunscreen Starting on the First Day After Ablative Fractional Skin Resurfacing

Unknown
NCT01512017Phase 3

Clinical Study on Veloderm for the Treatment of Split-thickness Skin Graft Donor Sites

Completed

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16